Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Oestrogen as a reticuloendothelial stimulant in patients with cancer.

Literature DB >> 5575972

Oestrogen as a reticuloendothelial stimulant in patients with cancer.

Abstract

Stimulation of reticuloendothelial activity may benefit patients with cancer. Oestrogenic compounds are known to stimulate reticuloendothelial phagocytic activity in animals and a similar effect is demonstrated in patients.The depression of reticuloendothelial phagocytic activity which follows radiotheraphy in the treatment of cancer can be prevented by the simultaneous administration of stilboestrol. Possibly this could be associated with a more favourable response to therapy, and a controlled trial is needed to establish this.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1971 PMID： 5575972 PMCID： PMC1795795 DOI： 10.1136/bmj.2.5758.367

Source DB: PubMed Journal: Br Med J ISSN： 0007-1447

26 in total

8. Sex hormones and skin tumorigenesis. I. Effect of the estrous cycle and castration on tumorigenesis by 7,12-dimethylbenz[a]-anthracene.

Authors: R R Bates
Journal: J Natl Cancer Inst Date: 1968-08 Impact factor: 13.506

5. [Effect of various oral contraceptives on the phagocytic activity of the reticulo-endothelial system (author's transl)].

Authors: E H Baar; H Hepp; H E Köhnlein
Journal: Arch Gynakol Date: 1974-05-14

9. Effect of stimulation of the host defense system by coenzyme Q 10 on dibenzpyrene-induced tumors and infection with Friend leukemia virus in mice.

Authors: E G Bliznakov
Journal: Proc Natl Acad Sci U S A Date: 1973-02 Impact factor: 11.205

10. Hypothesis: breast cancer regression under oestrogen therapy.

Authors: B A Stoll
Journal: Br Med J Date: 1973-08-25

Oestrogen as a reticuloendothelial stimulant in patients with cancer.

1. COMBINATION THERAPY WITH CYCLOPHOSPHAMIDE AND ZYMOSAN ON A SPONTANEOUS MAMMARY CANCER IN MICE.

2. OESTROGEN: THE NATURAL STIMULANT OF BODY DEFENCE.

3. Protective activity of fractions of tubercle bacilli against isologous tumours in mice.

4. Hormonal modification of tissue reactions to ionizing radiation.

5. A histological explanation for the beneficial action of endocrine therapy in carcinoma of the prostate.

6. The influence of various hormones on the reticulo-endothelial system: endocrine control of body defense.

7. An experimental study on the effect of reticuloendothelial activity on metastasis and recurrence of tumor.

8. Sex hormones and skin tumorigenesis. I. Effect of the estrous cycle and castration on tumorigenesis by 7,12-dimethylbenz[a]-anthracene.

9. Reticulo-endothelial activity in humans with cancer.

10. Sex differences in tumour growth and lymphoid reactions in mice with Ehrlich's ascites carcinoma.

1. Letter: Variations in leucocyte count during menstrual cycle.

2. Hormone replacement therapy and the general practitioner.

3. Distribution of mononuclear cells during pregnancy.

4. Immunosuppressive effect of estrogen on thymic dependent lymphocytic blastogenesis.

5. [Effect of various oral contraceptives on the phagocytic activity of the reticulo-endothelial system (author's transl)].

6. The control of cancer spread by the reticuloendothelial system.

7. Reticuloendothelial activity and cancer.

8. Effects of oestrogens and pregnancy on the distribution of sheep erythrocytes and the antibody response in mice.

9. Effect of stimulation of the host defense system by coenzyme Q 10 on dibenzpyrene-induced tumors and infection with Friend leukemia virus in mice.

10. Hypothesis: breast cancer regression under oestrogen therapy.